Concepedia

Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa

David Marín, Sarah Marktel, Richard Szydlo, John P. Klein, Marco Bua, Nicola Foot, Eduardo Olavarría, Pat Shepherd, Edward Kanfer, John M. Goldman,

The Lancet · 2003 · 35 citations · 4 references

DOI

Concepts

References

4

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Brian Druker, Moshe Talpaz, Debra Resta et al. · New England Journal of Medicine · 2001 · 5.2K citations · Full text

, , +12

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.6K citations · Full text

, , +10

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al. · New England Journal of Medicine · 2002 · 2K citations · Full text

, , +14

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

N. C. Allan, P.C.A. Shepherd, S Richards · The Lancet · 1995 · 405 citations · Full text

, , +12